Site search

Clear filter
2880 results for '' found
INNER-B-APAC – Asian Pacific post-market clinical follow-up study in patients with thoracoabdominal aortic aneurysms treated with E-nside TAAA Multibranch Stent Graft System 〈NCT05954793〉
INNER-B-APAC – Asian Pacific post-market clinical follow-up study in patients with thoracoabdominal aortic aneurysms treated with E-nside TAAA Multibranch Stent Graft System 〈NCT05954793〉
/
Prospective, Multi-Center Study using Bearing nsPVA Embolization Particles for the Treatment of uTErine fibRoids with Uterine Artery Embolization: BETTER-UAE (NCT06153667)
Prospective, Multi-Center Study using Bearing nsPVA Embolization Particles for the Treatment of uTErine fibRoids with Uterine Artery Embolization: BETTER-UAE (NCT06153667)
/
MRDRIVE-ALL: Minimal Residual Disease Driven Intervention in Elderly Acute Lymphoblastic Leukaemia (Trial Not Registered)
/
International Registry for Men with Advanced Prostate Cancer (IRONMAN) (NCT03151629)
/
A randomised double-blinded interventional pilot of Zoely and Zoloft to treat Premenstrual Dysphoric Disorder (ACTRN12623000496617p)
A randomised double-blinded interventional pilot of Zoely and Zoloft to treat Premenstrual Dysphoric Disorder (ACTRN12623000496617p)
/
A Centralized Platform study for Functional High Risk Multiple Myeloma (ACTRN12625000429459)
A Centralized Platform study for Functional High Risk Multiple Myeloma (ACTRN12625000429459)
/
A program of yoga in a randomised control study in people with atrial fibrillation (ACTRN12624000264583)
A program of yoga in a randomised control study in people with atrial fibrillation (ACTRN12624000264583)
/
A Randomized, Double-blind, Placebo-Controlled, Multicenter, Phase 3 Study to Evaluate the Safety, Tolerability, and Efficacy of XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic
A Randomized, Double-blind, Placebo-Controlled, Multicenter, Phase 3 Study to Evaluate the Safety, Tolerability, and Efficacy of XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic
/
A Randomized, Double-blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate the Safety, Tolerability, and Efficacy of XEN1101 as Adjunctive Therapy in Focal-Onset Seizures (NCT05614063)
A Randomized, Double-blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate the Safety, Tolerability, and Efficacy of XEN1101 as Adjunctive Therapy in Focal-Onset Seizures (NCT05614063)
/
A Phase 1/2 Dose-escalation Study Evaluating the Safety, Tolerability, and Efficacy of VX-522 in Subjects 18 Years of Age and Older With Cystic Fibrosis and a CFTR Genotype Not Responsive to CFTR
A Phase 1/2 Dose-escalation Study Evaluating the Safety, Tolerability, and Efficacy of VX-522 in Subjects 18 Years of Age and Older With Cystic Fibrosis and a CFTR Genotype Not Responsive to CFTR
/
18 19 20 21 22